HUMA – humacyte, inc. (US:NASDAQ)
Stock Stats
News
Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update
Humacyte, Inc. (NASDAQ: HUMA) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $25.00 price target on the stock.
Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025
Humacyte, Inc. Announces Pricing of Public Offering of Common Stock
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
Form PRE 14A Humacyte, Inc. For: Jun 10
Form 4 Humacyte, Inc. For: Apr 14 Filed by: Scheessele William John
Form 4 Humacyte, Inc. For: Apr 10 Filed by: Sander Dale A.
Form 4 Humacyte, Inc. For: Apr 10 Filed by: Parikh Shamik J
Form 4 Humacyte, Inc. For: Apr 08 Filed by: Sebelius Kathleen
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.